PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 78.37 USD 0.86% Market Closed
Market Cap: 6.3B USD

Wall Street
Price Targets

PTCT Price Targets Summary
PTC Therapeutics Inc

Wall Street analysts forecast PTCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PTCT is 83.37 USD with a low forecast of 55.55 USD and a high forecast of 123.9 USD.

Lowest
Price Target
55.55 USD
29% Downside
Average
Price Target
83.37 USD
6% Upside
Highest
Price Target
123.9 USD
58% Upside
PTC Therapeutics Inc Competitors:
Price Targets
HPHA
Heidelberg Pharma AG
134% Upside
CNTB
Connect Biopharma Holdings Ltd
195% Upside
CGON
CG Oncology Inc
82% Upside
MIRM
Mirum Pharmaceuticals Inc
29% Upside
PHM
Pharma Mar SA
30% Upside
ZNTL
Zentalis Pharmaceuticals Inc
293% Upside
AGIO
Agios Pharmaceuticals Inc
12% Upside
MRSN
Mersana Therapeutics Inc
16% Upside

Revenue
Forecast

Revenue Estimate
PTC Therapeutics Inc

For the last 12 years the compound annual growth rate for PTC Therapeutics Inc's revenue is 30%. The projected CAGR for the next 4 years is 18%.

30%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
PTC Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
PTC Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PTCT's stock price target?
Price Target
83.37 USD

According to Wall Street analysts, the average 1-year price target for PTCT is 83.37 USD with a low forecast of 55.55 USD and a high forecast of 123.9 USD.

What is PTC Therapeutics Inc's Revenue forecast?
Projected CAGR
18%

For the last 12 years the compound annual growth rate for PTC Therapeutics Inc's revenue is 30%. The projected CAGR for the next 4 years is 18%.

Back to Top